Chemistry:Oleclumab
From HandWiki
Short description: Monoclonal antibody
Monoclonal antibody | |
---|---|
Type | ? |
Source | Human |
Target | 5'-nucleotidase NT5E |
Clinical data | |
Other names | MEDI9447 |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
KEGG | |
Chemical and physical data | |
Formula | C6348H9826N1710O1998S40 |
Molar mass | 143350.81 g·mol−1 |
Oleclumab (INN;[1] development code MEDI9447) is a human monoclonal antibody targeting the ectonucleotidase CD73 that was designed for the treatment of pancreatic and colorectal and other cancers.[2]
This drug was developed by MedImmune/AstraZeneca.[3]
References
- ↑ World Health Organization (2016). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 116". WHO Drug Information 30 (4). https://www.who.int/medicines/publications/druginformation/innlists/PL116.pdf.
- ↑ ClinicalTrial.gov for Oleclumab
- ↑ Statement On A Nonproprietary Name Adopted By The USAN Council - Oleclumab, American Medical Association.
![]() | Original source: https://en.wikipedia.org/wiki/Oleclumab.
Read more |